239 related articles for article (PubMed ID: 33343836)
21. Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2.
Ghossoub R; Lembo F; Rubio A; Gaillard CB; Bouchet J; Vitale N; Slavík J; Machala M; Zimmermann P
Nat Commun; 2014 Mar; 5():3477. PubMed ID: 24637612
[TBL] [Abstract][Full Text] [Related]
22. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
Zimmermann P; Zhang Z; Degeest G; Mortier E; Leenaerts I; Coomans C; Schulz J; N'Kuli F; Courtoy PJ; David G
Dev Cell; 2005 Sep; 9(3):377-88. PubMed ID: 16139226
[TBL] [Abstract][Full Text] [Related]
23. Distinct functions of dimeric and monomeric scaffold protein Alix in regulating F-actin assembly and loading of exosomal cargo.
Qiu X; Campos Y; van de Vlekkert D; Gomero E; Tanwar AC; Kalathur R; Weesner JA; Bongiovanni A; Demmers J; d'Azzo A
J Biol Chem; 2022 Oct; 298(10):102425. PubMed ID: 36030822
[TBL] [Abstract][Full Text] [Related]
24. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
Hwangbo C; Kim J; Lee JJ; Lee JH
Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
[TBL] [Abstract][Full Text] [Related]
25. Get on the exosome bus with ALIX.
Hurley JH; Odorizzi G
Nat Cell Biol; 2012 Jun; 14(7):654-5. PubMed ID: 22743708
[TBL] [Abstract][Full Text] [Related]
26. Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis.
Pradhan AK; Modi J; Maji S; Kumar A; Bhoopathi P; Mannangatti P; Guo C; Afosah DK; Mochel MC; Mukhopadhyay ND; Kirkwood JM; Wang XY; Desai UR; Sarkar D; Emdad L; Das SK; Fisher PB
Mol Cancer Ther; 2023 Oct; 22(10):1115-1127. PubMed ID: 37721536
[TBL] [Abstract][Full Text] [Related]
27. Syntenin and CD63 Promote Exosome Biogenesis from the Plasma Membrane by Blocking Cargo Endocytosis.
Ai Y; Guo C; Garcia-Contreras M; Sanchez LS; Saftics A; Shodubi O; Raghunandan S; Xu J; Tsai SJ; Dong Y; Li R; Jovanovic-Talisman T; Gould S
bioRxiv; 2023 Jun; ():. PubMed ID: 37292617
[TBL] [Abstract][Full Text] [Related]
28. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines.
Koo TH; Lee JJ; Kim EM; Kim KW; Kim HD; Lee JH
Oncogene; 2002 Jun; 21(26):4080-8. PubMed ID: 12037664
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
30. The postsynaptic density 95/disc-large/zona occludens protein syntenin directly interacts with frizzled 7 and supports noncanonical Wnt signaling.
Luyten A; Mortier E; Van Campenhout C; Taelman V; Degeest G; Wuytens G; Lambaerts K; David G; Bellefroid EJ; Zimmermann P
Mol Biol Cell; 2008 Apr; 19(4):1594-604. PubMed ID: 18256285
[TBL] [Abstract][Full Text] [Related]
31. PDZ tandem of human syntenin: crystal structure and functional properties.
Kang BS; Cooper DR; Jelen F; Devedjiev Y; Derewenda U; Dauter Z; Otlewski J; Derewenda ZS
Structure; 2003 Apr; 11(4):459-68. PubMed ID: 12679023
[TBL] [Abstract][Full Text] [Related]
32. Concentration-Normalized Electroanalytical Assaying of Exosomal Markers.
Li Q; Tofaris GK; Davis JJ
Anal Chem; 2017 Mar; 89(5):3184-3190. PubMed ID: 28192902
[TBL] [Abstract][Full Text] [Related]
33. Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.
Das SK; Kegelman TP; Pradhan AK; Shen XN; Bhoopathi P; Talukdar S; Maji S; Sarkar D; Emdad L; Fisher PB
Mol Cancer Ther; 2019 Nov; 18(11):1997-2007. PubMed ID: 31345950
[TBL] [Abstract][Full Text] [Related]
34. Syntenin regulates hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes.
Deng L; Jiang W; Wang X; Merz A; Hiet MS; Chen Y; Pan X; Jiu Y; Yang Y; Yu B; He Y; Tu Z; Niu J; Bartenschlager R; Long G
J Hepatol; 2019 Jul; 71(1):52-61. PubMed ID: 30880226
[TBL] [Abstract][Full Text] [Related]
35. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
36. Anaplasma phagocytophilum Ats-1 enhances exosome secretion through Syntenin-1.
Li R; Ma Z; Zheng W; Xiao Y; Wang Z; Yi J; Wang Y; Chen C
BMC Microbiol; 2023 Sep; 23(1):271. PubMed ID: 37759206
[TBL] [Abstract][Full Text] [Related]
37. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
Grootjans JJ; Zimmermann P; Reekmans G; Smets A; Degeest G; Dürr J; David G
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13683-8. PubMed ID: 9391086
[TBL] [Abstract][Full Text] [Related]
38. Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.
Lee H; Kim Y; Choi Y; Choi S; Hong E; Oh ES
Biochem Biophys Res Commun; 2011 May; 409(1):148-53. PubMed ID: 21569759
[TBL] [Abstract][Full Text] [Related]
39. Targeting tumor invasion: the roles of MDA-9/Syntenin.
Kegelman TP; Das SK; Emdad L; Hu B; Menezes ME; Bhoopathi P; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Expert Opin Ther Targets; 2015 Jan; 19(1):97-112. PubMed ID: 25219541
[TBL] [Abstract][Full Text] [Related]
40. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival.
Yang Y; Hong Q; Shi P; Liu Z; Luo J; Shao Z
Breast Cancer Res; 2013 Jun; 15(3):R50. PubMed ID: 23786877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
